Suzanne R. Thibodeaux, MD, PhD

Division

• Laboratory & Genomic Medicine

Additional Titles

• Medical Director, Apheresis Center – Barnes-Jewish Hospital
• Medical Director, Cellular Therapy Laboratory – Barnes-Jewish Hospital
• Medical Director, Transfusion Medicine and Blood Bank Services – Barnes-Jewish Hospital
• Director, Blood Banking and Transfusion Medicine Fellowship Program
• Associate Director, Clinical Pathology Residency Program
• Director, Advanced Clinical Rotation, Gateway Curriculum, Washington University School of Medicine

Education

• BS, Cell & Molecular Biology: Tulane University, New Orleans, LA (2005)
• PhD, Cell & Molecular Biology: University of Texas Health Science Center at San Antonio, San Antonio, TX (2011)
• MD: University of Texas Health Science Center at San Antonio, San Antonio, TX (2013)
• Residency, Clinical Pathology: Hospital of the University of Pennsylvania, Philadelphia, PA (2016)
• Fellowship, Blood Banking and Transfusion Medicine: Hospital of the University of Pennsylvania, Philadelphia, PA (2017)

Board Certifications

• American Board of Pathology, Clinical Pathology, 2016
• American Board of Pathology, Blood Banking/Transfusion Medicine, 2017

Recognition

• Alpha Omega Alpha Honor Medical Society, 2012
• The William Pepper Fellowship Award for Outstanding Contributions to Laboratory Medicine, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 2016
• Paul E. Strandjord Young Investigator Research Grant, Academy of Clinical Laboratory Physicians and Scientists, 2017
• American Society for Apheresis, Fort Lauderdale, FL. People’s Choice Poster Abstract Award, 2017
• 40 under Forty Honoree, American Society of Clinical Pathology, 2020
• Academy of Educators, Washington University School of Medicine, St. Louis, MO, Induction 2021
• Honor Roll Award, Washington University School of Medicine, St. Louis, MO, 2021
• Pathology & Immunology Department Special Recognition Award, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 2021, 2022 and 2023
• Rising Star Award, Academy of Educators, Washington University School of Medicine, St. Louis, MO, 2023

Clinical Interests

• Transfusion Medicine with a focus on standard of care and novel cellular therapies
• Transfusion Medicine Education
• Transfusion Medicine process improvement

Research Interests

Dr. Thibodeaux’s research efforts focus on improving cellular therapies from the clinical laboratory perspective, as well as apheresis and transfusion medicine as it relates to cellular therapies. She is particularly interested in collaborative approached to process improvement in transfusion medicine and cellular therapies.

Selected Publications

Excellence for Safer Transfusions (BEST) Collaborative. Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study. Thibodeaux SR, Coble D, Day V, Fontaine MJ, Gabelli M, Gardiner N, Geach T, Schwartz J, Vasovic LV, Wyre R, Girdlestone J; Biomedical Excellence for Safer Transfusions (BEST) Collaborative. Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study. Transfusion. 2023 Apr;63(4):782-790. doi: 10.1111/trf.17311. Epub 2023 Mar 16. PMID: 36924403.

Transfusion support for patients with sickle cell disease. Wallace LR, Thibodeaux SR. Transfus Apher Sci. 2022 Oct;61(5):103556. doi: 10.1016/j.transci.2022.103556. Epub 2022 Aug 29. PMID: 36100552

Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID-19 pandemic: The BEST collaborative study. Lu W, Yazer M, Li N, Ziman A, Wendel S, Tang H, Tsang H, Titlestad K, Thibodeaux SR, Shih AW, Poisson JL, Pham T, Pandey S, Pagano MB, Shan H, Murphy M, Murphy C, Savioli ML, Kutner JM, Hess AS, Fontaine MJ, Fachini R, Dunbar NM, Kaufman RM; Biomedical Excellence for Safer Transfusions Collaborative. Transfusion. 2022 Aug;62(8):1559-1570. doi: 10.1111/trf.17023. Epub 2022 Jul 15. PMID: 35808950

Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis. Liu HD, Su L, Winters JL, Thibodeaux SR, Park YA, Wu Y, Schwartz J, Zubair AC, Schneiderman J, Gupta GK, Ramakrishnan S, Aqui NA. Cytotherapy. 2022 Sep;24(9):916-922. doi: 10.1016/j.jcyt.2022.02.007. Epub 2022 Apr 6. PMID: 35398001

Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies. Thibodeaux SR, Aqui NA, Park YA, Schneiderman J, Su LL, Winters JL, Zubair AC, Schwartz J, Liu HD; Immune Effector Cell Therapy Subcommittee, Clinical Applications Committee, American Society for Apheresis. J Clin Apher. 2022 Jun;37(3):223-236. doi: 10.1002/jca.21964. Epub 2022 Jan 27. PMID: 35085413

Updates in Blood Banking and Transfusion Medicine. Thibodeaux SR. Clin Lab Med. 2021 Dec;41(4):xiii-xiv. doi: 10.1016/j.cll.2021.09.001. PMID: 34689976

Volume determination methods for hematopoietic progenitor cell products collected by apheresis. Tang MS, Sempek DS, Rensing KJ, Thibodeaux SR. Cytotherapy. 2021 Nov;23(11):991-995. doi: 10.1016/j.jcyt.2021.07.004. Epub 2021 Aug 31. PMID: 34479818

IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer. Thibodeaux SR, Barnett BB, Pandeswara S, Wall SR, Hurez V, Dao V, Sun L, Daniel BJ, Brumlik MJ, Drerup J, Padrón Á, Whiteside T, Kryczek I, Zou W, Curiel TJ. Clin Cancer Res. 2021 Jul 1;27(13):3661-3673. doi: 10.1158/1078-0432.CCR-20-4594. Epub 2021 Mar 26. PMID: 33771857

A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity. Thibodeaux SR, McKenna DH, Szczepiorkowski ZM, Fontaine MJ, Kelley L, Reems JA, Young PP; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion. 2020 Aug; 60(8):1811-1820. doi: 10.1111/trf.15899. Epub 2020 Jul 12. PMID: 32654200.

Commentary on Hemolytic Anemia and Thrombocytopenia: How to Treat? Thibodeaux SR. Clin Chem. 2020 Jun 1;66(6):767. doi: 10.1093/clinchem/hvaa042. PMID: 32470129.

---

Assistant
Susan Keen
keen@wustl.edu
314-273-8136